Scalable Production of a De Novo SARS-CoV-2 Antiviral Miniprotein in Escherichia coli
Background/Objectives: The rapid emergence of SARS-CoV-2 variants that evade neutralizing antibodies underscores the need for new antiviral biologics that integrate precise molecular design with scalable, cost-effective manufacturing. Computationally designed miniproteins targeting the spike protein’s receptor-binding...
Jinhwan Shin, Eu-min Kim, Jun-Hong Jang et al.
· Pharmaceutics · 0 citations